Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.
Tong TML, Fiocco M, van Duijn-de Vreugd JJ, Lutjeboer J, Speetjens FM, Tijl FGJ, Sitsen ME, Zoethout RWM, Martini CH, Vahrmeijer AL, van der Meer RW, van Rijswijk CSP, van Erkel AR, Kapiteijn E, Burgmans MC. Tong TML, et al. Cardiovasc Intervent Radiol. 2024 May 6. doi: 10.1007/s00270-024-03733-w. Online ahead of print. Cardiovasc Intervent Radiol. 2024. PMID: 38709262 No abstract available.
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.
Tong TML, Fiocco M, van Duijn-de Vreugd JJ, Lutjeboer J, Speetjens FM, Tijl FGJ, Sitsen ME, Zoethout RWM, Martini CH, Vahrmeijer AL, van der Meer RW, van Rijswijk CSP, van Erkel AR, Kapiteijn E, Burgmans MC. Tong TML, et al. Cardiovasc Intervent Radiol. 2024 Apr 8. doi: 10.1007/s00270-024-03713-0. Online ahead of print. Cardiovasc Intervent Radiol. 2024. PMID: 38587534
Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period.
Tong TML, Bastiaannet E, Speetjens FM, Blank CU, Luyten GPM, Jager MJ, Marinkovic M, Vu THK, Rasch CRN, Creutzberg CL, Beenakker JM, Hartgrink HH, Bosch JJJ, Kiliç E, Naus NC, Yavuzyigitoglu S, van Rij CM, Burgmans MC, Kapiteijn EHW. Tong TML, et al. Cancers (Basel). 2023 Nov 15;15(22):5419. doi: 10.3390/cancers15225419. Cancers (Basel). 2023. PMID: 38001679 Free PMC article.
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial.
Tong TML, Burgmans MC, Speetjens FM, van Erkel AR, van der Meer RW, van Rijswijk CSP, Jonker-Bos MA, Roozen CFM, Sporrel-Blokland M, Lutjeboer J, van Persijn van Meerten EL, Martini CH, Zoethout RWM, Tijl FGJ, Blank CU, Kapiteijn E. Tong TML, et al. Cardiovasc Intervent Radiol. 2023 Mar;46(3):350-359. doi: 10.1007/s00270-022-03338-1. Epub 2023 Jan 9. Cardiovasc Intervent Radiol. 2023. PMID: 36624292 Clinical Trial.
Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis.
Tong TML, Samim M, Kapiteijn E, Meijer TS, Speetjens FM, Brüning R, Schroeder TH, El-Sanosy S, Maschke H, Wacker FK, Vogel A, Dewald CLA, Goeman JJ, Burgmans MC. Tong TML, et al. Cardiovasc Intervent Radiol. 2022 Sep;45(9):1304-1313. doi: 10.1007/s00270-022-03225-9. Epub 2022 Aug 3. Cardiovasc Intervent Radiol. 2022. PMID: 35922562 Free PMC article.
HKG: an open genetic variant database of 205 Hong Kong cantonese exomes.
Ou M, Leung HC, Leung AW, Luk HM, Yan B, Liu CM, Tong TM, Mok MT, Ko WM, Law WC, Lam TW, Lo IF, Luo R. Ou M, et al. Among authors: tong tm. NAR Genom Bioinform. 2022 Feb 8;4(1):lqac005. doi: 10.1093/nargab/lqac005. eCollection 2022 Mar. NAR Genom Bioinform. 2022. PMID: 35156024 Free PMC article.
41 results